New approach combines oncolytic virotherapy and adoptive T cell therapy for cancer treatment
by Bob Yirka , Medical XpressScheme of genome editing of PDL1 by eOA effectively improved virotherapy and adoptive T-cell therapy. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-02
Updated on: March 05,2024
14

New approach combines oncolytic virotherapy and adoptive T cell therapy for cancer treatment
by Bob Yirka , Medical XpressScheme of genome editing of PDL1 by eOA effectively improved virotherapy and adoptive T-cell therapy. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-02
Updated on:March 05,2024
14
